Cytokinetics, Inc. (CYTK)

64.22 -5.88 (-8.39%) USD  |  NASDAQ  |  Feb 25, 12:23
More

Cytokinetics Preferred Securities out of Shareholders Equity (Quarterly)

Preferred Securities out of Shareholders Equity (Quarterly) Chart

View Preferred Securities out of Shareholders Equity (Quarterly) for CYTK.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Preferred Securities out of Shareholders Equity (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Preferred Securities out of Shareholders Equity (Quarterly) Range, Past 5 Years

View Preferred Securities out of Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Preferred Securities out of Shareholders Equity (Quarterly) Benchmarks

View Preferred Securities out of Shareholders Equity (Quarterly) Benchmarks
Start Trial
Bristol Myers Squibb Co. --
Molina Healthcare, Inc. --
Lifecore Biomedical, Inc. Upgrade
Fortrea Holdings, Inc. --
Ionis Pharmaceuticals, Inc. --